↓ Skip to main content

Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?

Overview of attention for article published in BMC Public Health, December 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
Published in
BMC Public Health, December 2014
DOI 10.1186/s12914-014-0037-4
Pubmed ID
Authors

Gorik Ooms, Lisa Forman, Owain D Williams, Peter S Hill

Abstract

BackgroundThe heads of the Global Fund and the GAVI Alliance have recently promoted the idea of an international tiered pricing framework for medicines, despite objections from civil society groups who fear that this would reduce the leeway for compulsory licenses and generic competition. This paper explores the extent to which an international tiered pricing framework and the present leeway for compulsory licensing can be reconciled, using the perspective of the right to health as defined in international human rights law.DiscussionWe explore the practical feasibility of an international tiered pricing and compulsory licensing framework governed by the World Health Organization. We use two simple benchmarks to compare the relative affordability of medicines for governments ¿ average income and burden of disease ¿ to illustrate how voluntary tiered pricing practice fails to make medicines affordable enough for low and middle income countries (if compared with the financial burden of the same medicines for high income countries), and when and where international compulsory licenses should be issued in order to allow governments to comply with their obligations to realize the right to health.SummaryAn international tiered pricing and compulsory licensing framework based on average income and burden of disease could ease the tension between governments¿ human rights obligation to provide medicines and governments¿ trade obligation to comply with the Agreement on Trade-Related Aspects of Intellectual Property Rights.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 72 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 18%
Student > Master 13 18%
Student > Bachelor 6 8%
Student > Doctoral Student 5 7%
Professor 4 5%
Other 10 14%
Unknown 22 30%
Readers by discipline Count As %
Medicine and Dentistry 10 14%
Social Sciences 9 12%
Pharmacology, Toxicology and Pharmaceutical Science 8 11%
Agricultural and Biological Sciences 5 7%
Economics, Econometrics and Finance 4 5%
Other 16 22%
Unknown 21 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2017.
All research outputs
#6,333,477
of 25,374,917 outputs
Outputs from BMC Public Health
#6,713
of 17,512 outputs
Outputs of similar age
#77,434
of 360,190 outputs
Outputs of similar age from BMC Public Health
#86
of 218 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 17,512 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.4. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,190 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.